|
UNC13B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.348200E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.092400E-02 |
| Normal-vs-Stage2 |
8.473600E-01 |
| Normal-vs-Stage3 |
1.047810E-02 |
| Normal-vs-Stage4 |
5.241800E-04 |
| Stage1-vs-Stage2 |
2.905400E-01 |
| Stage1-vs-Stage3 |
1.806610E-01 |
| Stage1-vs-Stage4 |
1.086320E-02 |
| Stage2-vs-Stage3 |
5.822200E-02 |
| Stage2-vs-Stage4 |
6.703900E-03 |
| Stage3-vs-Stage4 |
2.630800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.592500E-02 |
| Normal-vs-AfricanAmerican |
3.213900E-02 |
| Normal-vs-Asian |
2.700600E-01 |
| Caucasian-vs-AfricanAmerican |
5.281600E-01 |
| Caucasian-vs-Asian |
7.322600E-01 |
| AfricanAmerican-vs-Asian |
4.031200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.802440E-02 |
| Normal-vs-Female |
4.600000E-02 |
| Male-vs-Female |
3.647600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.102230E-01 |
| Normal-vs-Age(41-60Yrs) |
1.716220E-02 |
| Normal-vs-Age(61-80Yrs) |
8.112200E-02 |
| Normal-vs-Age(81-100Yrs) |
4.293800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.102000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.542800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.411800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.979600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.486200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.828000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.719200E-01 |
| Classical-VS-Follicular |
2.600000E-01 |
| Classical-VS-Other |
3.739000E-01 |
| Classical-VS-Normal |
3.979800E-02 |
| Tall-VS-Follicular |
5.624100E-02 |
| Tall-VS-Other |
6.887200E-01 |
| Tall-VS-Normal |
1.049920E-02 |
| Follicular-VS-Other |
5.991600E-02 |
| Follicular-VS-Normal |
5.453400E-01 |
| Other-VS-Normal |
5.163800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.588830E-01 |
| Normal-vs-N1 |
1.228000E-02 |
| N0-vs-N1 |
9.704400E-02 |
|
|
